About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Experts Available to Discuss NEJM Editorial on Use of PARP Inhibitors in Triple-Negative Breast Cancer

by Kathy Jones on January 7, 2011 at 9:16 PM
Font : A-A+

 Experts Available to Discuss NEJM Editorial on Use of PARP Inhibitors in Triple-Negative Breast Cancer

A significant increase in clinical benefit, a measure of durable response or disease stabilization, as well as an increase in progression-free survival is offered by the use of the PARP inhibitor iniparib in combination with standard chemotherapy to treat metastatic triple-negative breast cancer, according to a current New England Journal of Medicine study.

NEJM is releasing the study in its Online First edition on Wednesday, January 5, where it will be published with an editorial written by Lisa A. Carey, MD, professor of Medicine and Medical Director of the UNC Breast Center and Norman E. Sharpless, MD, professor of Medicine and Genetics. Both are faculty in the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center, where Carey is Associate Director of Clinical Science and Sharpless is Associate Director of Translational Research.

Advertisement

In the editorial, the UNC researchers explain the excitement about this new class of drugs and the importance of this trial. They also highlight the reasons that caution as well as enthusiasm is warranted. The authors look forward to the confirmation of these results in a larger, phase 3 trial as well as trials to answer important research questions about triple negative breast cancer, PARP inhibitor mechanism of action, long-term safety and efficacy.



Source: Newswise
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World AIDS Day 2022 - Equalize!
Test Your Knowledge on Sugar Intake and Oral Health
Test  Your Knowledge on Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Pagets disease of the breast Mastitis Cancer and Homeopathy Breast Cancer Facts Cancer Facts Cancer Tattoos A Body Art Breasts - Structures and Types Breast Lumps 

Most Popular on Medindia

Daily Calorie Requirements Color Blindness Calculator Drug Side Effects Calculator Blood - Sugar Chart Selfie Addiction Calculator Hearing Loss Calculator Blood Donation - Recipients Iron Intake Calculator Vent Forte (Theophylline) Drug Interaction Checker
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Experts Available to Discuss NEJM Editorial on Use of PARP Inhibitors in Triple-Negative Breast Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests